Biological and mechanical evaluation of a Bio-Hybrid scaffold for autologous valve tissue engineering

- We report detailed biological and mechanical investigations of a Bio-Hybrid scaffold.
- Optimized polymer thickness yielded desired biological and mechanical properties.
- Bio-Hybrid scaffold revealed hVIC proliferation with dense ECM deposition.
- Biaxial testing indicated that Bio-Hybrid scaffolds are mechanically stronger than native valves.
- Bio-Hybrid scaffold is a promising material for autologous valve tissue engineering.

Major challenge in heart valve tissue engineering for paediatric patients is the development of an autologous valve with regenerative capacity. Hybrid tissue engineering approach is recently gaining popularity to design scaffolds with desired biological and mechanical properties that can remodel post implantation. In this study, we fabricated aligned nanofibrous Bio-Hybrid scaffold made of decellularized bovine pericardium: polycaprolactone-chitosan with optimized polymer thickness to yield the desired biological and mechanical properties. CD44+, αSMA+, Vimentin+ and CD105− human valve interstitial cells were isolated and seeded on these Bio-Hybrid scaffolds. Subsequent biological evaluation revealed interstitial cell proliferation with dense extra cellular matrix deposition that indicated the viability for growth and proliferation of seeded cells on the scaffolds. Uniaxial mechanical tests along axial direction showed that the Bio-Hybrid scaffolds has at least 20 times the strength of the native valves and its stiffness is nearly 3 times more than that of native valves. Biaxial and uniaxial mechanical studies on valve interstitial cells cultured Bio-Hybrid scaffolds revealed that the response along the axial and circumferential direction was different, similar to native valves. Overall, our findings suggest that Bio-Hybrid scaffold is a promising material for future development of regenerative heart valve constructs in children.

397